Rochelle Fuhrmann

Rochelle Fuhrmann

Directeur Financier/CFO chez
Maternal Newborn Health Innovations Corp.
56 ans
Health Technology
Finance
Consumer Services

Profil

Rochelle Fuhrmann is currently Chief Financial Officer-Life Sciences at Dickinson & Co. and Chief Financial Officer at Maternal Newborn Health Innovations PBC.
Former roles include Independent Director at Histogen, Inc., Director-Accounting Policy at AT&T, Inc. from 1996 to 2006, Independent Non-Executive Director at Advanz Pharma Corp.
Ltd. from 2015 to 2018, Director at Advanz Pharma Corp.
(Ontario), Vice President-Audit & Enterprise Risk Management at Becton, Dickinson & Co. from 2017 to 2022, Chief Financial Officer at Amneal Pharmaceuticals LLC from 2014 to 2015, Senior VP-Finance & Head-Investor Relations at Warner Chilcott Plc in 2013, and Chief Financial Officer & Senior Vice President at Becton Dickinson India Pvt Ltd. Education includes undergraduate studies at the University of Rhode Island.

Postes actifs de Rochelle Fuhrmann

SociétésPosteDébut
Corporate Officer/Principal -
Directeur Financier/CFO -

Anciens postes connus de Rochelle Fuhrmann

SociétésPosteFin
BECTON, DICKINSON AND COMPANY Comptroller/Controller/Auditor 01/10/2022
ADVANZ PHARMA CORP. LIMITED Directeur/Membre du Conseil 06/09/2018
Directeur Financier/CFO 01/03/2015
Investor Relations Contact 01/11/2013
AT&T INC. Corporate Officer/Principal 01/01/2006
Voir l'expérience en détail de Rochelle Fuhrmann

Formation de Rochelle Fuhrmann

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

62

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Finance

Consumer Services

Communications

Health Technology

Technology Services

Health Technology

Health Technology

Health Services

Health Technology

  1. Bourse
  2. Insiders
  3. Rochelle Fuhrmann